Navigation Links
Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS

Jason S. Wood, Ph.D. Varian, Inc.

Introduction

Testing for drugs of abuse (DoA) is becoming more prevalent in various environments, including forensics and social justice environments as well as in sporting events. Non-heroin opiates such as morphine, oxycodone, and hydrocodone are appearing increasingly in drug indicator data. For example, in San Francisco, the number of emergency department mentions of oxycodone overdose increased 110 percent in a one year peroid between 2001 and 20021. A US Department of Justice report from the Bureau of Justice Statistics in 2004 showed that the top four drugs utilized by high school seniors (and the percentage of those reporting their use in the last 12 months) were: 1) Alcohol (70.6%), 2) Marijuana (34.3%), 3) Stimulants (10.0%) and 4) Non-heroin Opiates (9.5%)2. Moreover, the US Drug Enforcement Administration (USDEA) reports that since 1990, there has been about a 3-fold increase in morphine products in the United States3.

This application note describes a rapid (5 min), dilute-and-shoot method for the determination of morphine and one of its major metabolites (morphine-glucuronide) in biological fluids (saliva and urine). This method has the advantage that it does not require lengthy derivatization processes (as in GC/MS) and, therefore, can be used in a high-throughput screen environment. It utilizes the advanced features of the Varian 500-MS to divert salts and contaminating proteins away from the API ion source and includes Varians patented OnTrak OraTube as a sampling mechanism for the saliva.

Instrumentation

Varian 500-MS LC Ion Trap Mass Spectrometer equipped with an ESI source

Two Varian ProStar 210 Solvent Delivery Modules

CTC Analytics HTS PAL AutoSampler

Materials and Reagents

All chemicals were reagent or HPLC grade from Sigma-Aldrich (St. Louis, MO) with the exception of the morphine and morphine-glucuronide (Cerilliant, Little Rock, TX). Drugs of abuse urine control was obtained from Utak Laboratories, Inc (Valencia, CA). OnTrak OraTube was obtained from the local Varian sales office.

Sample Preparation

All stock solutions were prepared in 50:50 Methanol:Water at 1 mg/mL. All dilutions were prepared in 5% aqueous methanol + 0.1% acetic acid. Varian OnTrak OraTube (Cat# 6902051) (for obtaining a saliva sample) was used according to its instructions. Utak Laboratories Drugs of Abuse Confirmation Standard (Cat# 98815) was prepared, according to its instructions, by adding 10 mL of HPLC grade water to the dried samples provided.

All saliva and urine samples were diluted 1:10 with 5% aqueous methanol containing 0.1% acetic acid before injection on the 500-MS.

Results and Discussion

The structures of morphine and one of its metabolites are shown in Figure 1. Glucuronidation (catalyzed by uridine-glucuronic transferase or UGTs) is a Phase II metabolism reaction which involves the addition of glucuronic acid from uridine-diphosphoglucuronide to the xenobiotic being metabolized. In general, morphine metabolism is undertaken by UGT2B7.

Typically, simple onsite kits such as the Varian OnTrak TesTcard perform preliminary screening for morphine usage, either on a random basis or as an incident-driven event. However, to eliminate false positives, a second, but more specific chemical method, such as GC/MS, is used as a confirmatory test. However, GC/MS methods for drugs-of-abuse testing are time-consuming, requiring the use of solid-phase extraction and derivatization with pentafluoropropionic anhydride/ pentafluoropropanol. The LC/MS method uses a fast gradient program for complete analysis in only five minutes. Due to the complexity of the final samples injected, a tandem MS technique is employed to increase the method selectivity; the MS/MS conditions are shown in the previous table. Figures 2 and 3 are the calibration curves for morphine and morphine-glucuronide, respectively. Excellent linearity can be demonstrated from 20 to 1000 pg (six points, triplicate runs) for morphine and 40 to 1000 pg (five points, triplicate runs) for morphine-glucuronide. The on column Limits of detection (LOD) and quantification (LOQ) are 10 and 20 pg (respectively) for morphine and 40 and 60 pg (respectively) for morphine-glucuronide. These limits are well within the limits required by the National Institute on Drug Abuse (NIDA) limits for opiates in saliva and urine: 40 ng/mL and 300 ng/mL, respectively.

Figure 4 shows the separation of morphine that was added to a sample of saliva taken with the OraTube sampler. Panel 1 shows the separation of morphine (Arrow marked B) from the salts and matrix interfering peaks (Arrow A). These peaks are now removed when compared to a saliva sample further spiked with morphine (to confirm its identity) but run with the automated 6-port valve of the 500-MS plumbed as a diverter valve.

The diverter valve is an important tool which allows direct injection of urine samples into the ESI source, preventing contamination of the ESI source with urinary salts and extending the maintenance cycle time. To demonstrate this, we have placed a UV detector in-line between the HPLC column and the MS source so that the sample was analyzed by the UV detector prior to the MS. Figure 5 shows the detection of morphine-glucuronide in urine as detected by the 500-MS with the diverter valve, the expanded region on top shows the same sample as detected by UV/Vis at 214 nm.

The bottoming out of the chromatogram (at approximately 0.6 min, UV detection) is the sample void caused (usually) by a high concentration of salt eluting from the LC column.

Conclusion

This application note demonstrates the picogram detection, without derivatization, of morphine and its metabolite morphine-glucuronide in saliva or urine. The limit of quantitation for these analytes is well within the limits set by NIDA and SAMHSA for the detection of opiates in saliva and/or urine. More importantly, this method does not require the lengthy and often tedious derivatization as required in a GC/MS method. All compounds were found to be linear in the calibration range tested and all had very good correlation coefficients (average r2= 0.989).

Finally, this application demonstrates the use of two useful features of the 500-MS, the use of the built-in 6-port injection valve and the syringe pump. Together they can be used as a diverter valve to avoid potential damage to the electrospray interface by diverting salts away from the source and applying a make-up volume of solvent for maintaining optimum spray conditions.

References

1. NIDA InfoFacts Sept. 2004 (www.drugabuse.gov)

2. US Dept. Of Justice Bureau of Justice Statistics (www.ojp.usdoj.gov/bjs/dcf/du.html)

3. DEA Briefs and Background, Drugs and Drug Abuse www.usdoj.gov/dea/concern/morphine.html


'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
2. A New PCR-based Mycoplasma Detection Method
3. HSVision Molecular Beacon Detection Module Rapidly Detects Herpes Simplex Virus DNA
4. Detection and Identification of Phosphorylation Sites in Proteins Using LC/MS/MS with Neutral Fragment Loss Mapping
5. Detection of mRNAs on Cryosections of the Cardiovascular System Using DIG-Labeled RNA Probes
6. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
7. The DIG System Nonradioactive and Highly Sensitive Detection of Nucleic Acids
8. Quantitative Measurement of Cell Proliferation Using the BrdU ELISA: A Comparison Between Colorimetric and Chemiluminescent Detection
9. Quantification of Nucleosomes in Serum by the Cell Death Detection ELISAplus
10. A Further Step in Understanding Apoptosis Direct Detection of PARP Cleavage
11. In Situ Cell Death Detection Kit
Post Your Comments:
(Date:7/29/2015)... 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) today ... Financial Officer has resigned.  The Company has hired ... retired in December 2014, as full time interim CFO ... Andy Ashworth began his employment ... smooth transition.  Andy was the Company,s CFO from September ...
(Date:7/29/2015)... , July 29, 2015 ... announced the addition of the "Global Biosimilars ... offering. The Global Biosimilars Market, 2015 ... the rapidly growing biosimilars market. With the blockbuster ... to minimize costs, biosimilars are being viewed as ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE MKT: ... results will be released on Thursday, August 13, 2015, ... Time, Pfenex management will host a conference call to ... A press release outlining the financial results and business ... Please call 1-866-376-8058 (US) or 1-412-542-4131 (international) ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 2Global Biosimilars Market to 2025: Monoclonal Antibodies (mAbs), Insulin, Interferons, G-CSF/ GM-CSF, Erythropoietins and Others 3Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... Four Clinical Stage Product Candidates Adds to Robust ... ... Access Pharmaceuticals, Inc.,(OTC Bulletin Board: ACCP) and MacroChem Corporation (OTC ... agreement,providing for Access to acquire MacroChem through the issuance of 2.5,million ...
... (Nasdaq: ALXN ), today announced that the Company ... Tuesday, July 29, 2008, at,10:00 a.m. Eastern Time (ET), ... the second quarter ended June 30, 2008. Alexion,anticipates releasing ... 29, 2008., To participate in this conference call, ...
... Exchange between Physician Community and Leading Biotechnology and ... ... EMD Serono, Inc. announced,today that the company has adopted ... Interactions with Healthcare Professionals.,The revised voluntary Code, which builds on ...
Cached Biology Technology:Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 2Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 3Access Pharmaceuticals Signs Merger Agreement to Acquire MacroChem Corp. 4EMD Serono to Adopt Revised and Strengthened PhRMA Code 2EMD Serono to Adopt Revised and Strengthened PhRMA Code 3EMD Serono to Adopt Revised and Strengthened PhRMA Code 4
(Date:7/8/2015)... July 8, 2015 The consumer products ... summer,s must have products such as wearables, smart wallets & ... for biometrics based devices continues to rapidly grow.  Biometrics & ... NXTD ), Google Inc. (NASDAQ: GOOG ), Apple ... ), GoPro, Inc. (NASDAQ: GPRO ) and Baidu Inc. ...
(Date:7/2/2015)... 25, 2015 Research and ... "Next Generation Biometrics Market by Application, Technology, Function ... to their offering. The next generation biometrics ... at a CAGR of 17.9% between 2015 and 2020 ... for the market. Safran SA ( ...
(Date:6/26/2015)... June 26, 2015 ATL Technology, LLC, a top ... specialties in single use solutions, headquartered in Springville, ... (a California corporation with locations in ... San Jose, Costa Rica ). This acquisition ... with ATL Technology,s existing facility in ...
Breaking Biology News(10 mins):Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2
... Abstract:, The transfer of scientific data has ... grow in size and demand as open access sharing ... well for large files and can cause long transfer ... that allows open access sharing of scientific data and ...
... University scientists have developed a new way to identify ... breakthrough they believe ultimately could lead to a deeper ... from blue eyes to blood pressure problems. Writing ... scientists led by Leonid Kruglyak, a professor in Princeton,s ...
... chickens that consumed extremely high levels of melamine in their ... contaminant that exceeded U. S. Food and Drug Administration (FDA) ... check on the effects of melamine-contaminated feed in laying hens. ... Chemistry , a bi-weekly publication. Liying Zhang and colleagues ...
Cached Biology News:BioTorrents: An OA file sharing service and more 2BioTorrents: An OA file sharing service and more 3BioTorrents: An OA file sharing service and more 4BioTorrents: An OA file sharing service and more 5Genetic patterns rise from huge yeast samples 2Genetic patterns rise from huge yeast samples 3Genetic patterns rise from huge yeast samples 4
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
... 75 x 25 mm; approximately 1 mm ... of paraffin-embedded sections, sandblasted ... markings will not rub off or ... precleaned, store at ...
Donor feline serum and plasma...
8 different frozen tissues are mounted on positively charged glass slides...
Biology Products: